Fate Therapeutics
FATE
FATE
187 hedge funds and large institutions have $520M invested in Fate Therapeutics in 2023 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 60 increasing their positions, 57 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
3.66% less ownership
Funds ownership: 114.6% → 110.94% (-3.7%)
19% less capital invested
Capital invested by funds: $642M → $520M (-$122M)
55% less call options, than puts
Call options by funds: $173K | Put options by funds: $382K
Holders
187
Holding in Top 10
2
Calls
$173K
Puts
$382K
Top Buyers
| 1 | +$7.78M | |
| 2 | +$4.77M | |
| 3 | +$4.72M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.34M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.84M |
Top Sellers
| 1 | -$21.5M | |
| 2 | -$14.8M | |
| 3 | -$5.27M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$4.44M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$3.17M |